Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction.
Michael GrabnerJulja BurchardChi NguyenHaechung ChungNilesh GanganJ Jay BonifaceJohn A F ZupancicEric StanekPublished in: ClinicoEconomics and outcomes research : CEOR (2021)
Use of a novel prognostic test during pregnancy to identify women at risk of PTB combined with evidence-based treatment is estimated to reduce total costs while preventing PTBs and their consequences.